Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Early Data Suggests Many With HIV Accessed Obamacare

A significant proportion of those accessing marketplace insurance plans through Obamacare are people with HIV, according to a study from a major pharmacy benefits manager.

Published
22 April 2014
From
AIDSMeds
Motorbikes Speed Up HIV Test Results in Malawi

Improvements to Malawi’s network for transporting laboratory samples will help people living with HIV get vital test results quicker. The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) plans to work with motorcycle couriers Riders for Health to expand the laboratory samples transportation network in Malawi.

Published
22 April 2014
From
Bill & Melinda Gates Foundation (blog)
Gilead Sciences’ New Drug Applications for Cobicistat and Elvitegravir for HIV Therapy Accepted by U.S. FDA

Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s refiling of two New Drug Applications (NDA) for cobicistat, a pharmacoenhancing or “boosting” agent that increases blood levels of the protease inhibitors atazanavir and darunavir to enable once-daily dosing of these medicines in HIV therapy, and elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced adults.

Published
22 April 2014
From
Gilead press release
People living with HIV in the UK still have impaired health-related quality of life

People living with HIV in the UK have poorer health-related quality of life (HRQoL) compared to individuals in the general population, according to research presented at the

Published
22 April 2014
By
Michael Carter
NHS England agrees funding for life-saving hepatitis C drug

NHS England has approved an £18.7 million investment in a new drug for the treatment of hepatitis C. Around 500 patients with acute liver failure, and/or awaiting liver transplantation, are expected to benefit from the decision to fund Sofosbuvir.

Published
17 April 2014
From
NHS England (press release)
Abolishing HIV in Rwanda

The achievement of universal HIV coverage in one African country, Rwanda, has resulted in HIV diagnoses more than halving and annual incidence falling by 90%, the 2014 Treatment

Published
16 April 2014
By
Gus Cairns
Few patients attend HIV clinic after ED visit for postexposure care

Only half of people who were referred to HIV clinics for follow-up after presenting to the emergency department for nonoccupational postexposure prophylaxis actually attended the clinic for care.

Published
15 April 2014
From
Healio
Bristol-Myers Squibb Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of Atazanavir Sulfate with Cobicistat for People Living with HIV-1

If approved, atazanavir sulfate and cobicistat could offer patients living with HIV-1 a single tablet that eliminates the need to take a boosting agent in a separate tablet. Cobicistat is developed by Gilead Sciences, Inc.

Published
15 April 2014
From
Bristol-Myers Squibb press release
London election candidates urged to tackle HIV as numbers in the capital continue to increase

A leading HIV charity is calling on London’s councillors and political groups to tackle the high rates of HIV in their boroughs and improve support services for the growing number of people living with HIV, in the lead up to May elections.

Published
15 April 2014
From
NAT press release
Viral hepatitis more deadly than HIV in Europe

Viral hepatitis, which includes hepatitis C virus (HCV) and hepatitis B virus (HBV), was blamed for nearly 90,000 deaths in 2010, while HIV claimed slightly more than 8,000 lives.

Published
14 April 2014
From
Science Daily

Filter by country